AIM Vaccine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	169.52	342.58	494.27	583.14	635.18	646.74
Short-Term Investments	13.13	13.04	100.61	153.27	183.74	-
Trading Asset Securities	-	-	-	-	-	100
Cash & Short-Term Investments	182.64	355.62	594.87	736.42	818.91	746.74
Cash Growth	-54.55%	-40.22%	-19.22%	-10.07%	9.66%	-32.29%
Accounts Receivable	1,170	1,198	1,124	1,005	1,053	1,064
Other Receivables	-	11.64	44.5	57.33	5.95	15.82
Receivables	1,170	1,209	1,168	1,062	1,059	1,079
Inventory	369.76	347.41	462.61	509.86	504.74	367.4
Restricted Cash	10.54	28.94	47.59	42.24	11.17	22.32
Other Current Assets	118.37	101.72	114.07	132.02	155.34	142.75
Total Current Assets	1,851	2,043	2,387	2,483	2,549	2,359
Property, Plant & Equipment	3,075	3,108	3,479	3,522	3,488	2,871
Goodwill	271.45	271.45	271.45	271.45	482.9	482.9
Other Intangible Assets	937.48	236.94	268.81	288.63	305.94	311.73
Long-Term Deferred Tax Assets	122.67	128.61	109.97	95.33	-	-
Long-Term Deferred Charges	-	680.32	720.55	516.78	1,933	1,881
Other Long-Term Assets	76.78	76.67	76.72	85.34	117.6	167.48
Total Assets	6,335	6,544	7,314	7,262	8,876	8,072

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	62.96	79.98	50.89	60.36	73.58	51.76
Accrued Expenses	-	1,066	1,003	680.92	564.33	505.92
Short-Term Debt	-	1,116	1,122	1,151	966.61	397.39
Current Portion of Long-Term Debt	1,445	273.19	271.32	54.27	44.08	9.98
Current Portion of Leases	12.92	10.76	13.96	20.54	19.34	16.9
Current Income Taxes Payable	-	3.64	3.47	2.89	7.87	40.89
Current Unearned Revenue	19.38	23.56	41.31	63.04	62.02	45.65
Other Current Liabilities	1,512	520.41	583.63	568.45	511.96	501.56
Total Current Liabilities	3,052	3,093	3,090	2,602	2,250	1,570
Long-Term Debt	308.53	354.8	424.99	556.94	339.44	184.33
Long-Term Leases	4.39	2.1	8.54	12.43	29.19	41.83
Long-Term Unearned Revenue	156.25	149.32	154.42	159.99	127.44	85.03
Long-Term Deferred Tax Liabilities	7.18	8.81	25	41.16	269.01	491.83
Total Liabilities	3,528	3,608	3,703	3,372	3,015	2,373

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1,227	1,227	1,211	1,211	1,211	1,200
Retained Earnings	-2,709	-2,586	-1,911	-1,634	-332.68	-13.08
Comprehensive Income & Other	4,119	4,119	4,065	4,065	4,082	3,706
Total Common Equity	2,636	2,759	3,366	3,643	4,960	4,893
Minority Interest	170.35	177.32	245.59	246.82	900.67	806.7
Shareholders' Equity	2,807	2,937	3,611	3,890	5,861	5,699
Total Liabilities & Equity	6,335	6,544	7,314	7,262	8,876	8,072

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1,771	1,756	1,841	1,796	1,399	650.43
Net Cash (Debt)	-1,588	-1,401	-1,246	-1,059	-579.76	96.31
Net Cash Growth	-	-	-	-	-	-88.90%
Net Cash Per Share	-1.29	-1.14	-1.03	-0.87	-0.48	0.08
Filing Date Shares Outstanding	1,227	1,227	1,211	1,211	1,211	1,200
Total Common Shares Outstanding	1,227	1,227	1,211	1,211	1,211	1,200
Working Capital	-1,201	-1,050	-702.87	-118.96	298.91	788.64
Book Value Per Share	2.15	2.25	2.78	3.01	4.10	4.08
Tangible Book Value	1,427	2,251	2,825	3,083	4,171	4,098
Tangible Book Value Per Share	1.16	1.84	2.33	2.55	3.44	3.41
Buildings	-	1,022	1,035	1,024	806.39	682.19
Machinery	-	637.28	637.8	654.19	613.79	532.28
Construction In Progress	-	2,119	2,356	2,259	2,378	1,884
Leasehold Improvements	-	86.45	85.94	83.47	107.78	70.71